Central Nervous System Pharmacology Practice Questions

Q: Which enzyme is inhibited by caffeine?

Phosphodiesterase. **Explanation:** **Caffeine** belongs to the **Methylxanthine** class of drugs (along with theophylline and theobromine). Its primary mechanism of action involves the **non-selective inhibition of the enzyme Phosphodiesterase (PDE)**. 1. **Why Phosphodiesterase is correct:** PDE is responsible for the degradation of cyclic nucleotides (cAMP and cGMP). By inhibiting PDE, caffeine prevents the breakdown of **cAMP**, leading to increased intracellular levels of this second messenger. In the respiratory system, elevated cAMP causes bronchodilation and inhibits the release of inflammatory mediators. Additionally, caffeine acts as an **adenosine receptor antagonist** ($A_1$ and $A_2$ receptors), which further contributes to its CNS stimulant and bronchodilatory effects. 2. **Why other options are incorrect:** * **Monoamine oxidase (MAO):** This enzyme breaks down catecholamines (epinephrine, norepinephrine). While caffeine increases catecholamine release, it does not inhibit MAO. * **Alcohol dehydrogenase:** This is the primary enzyme for ethanol metabolism; caffeine has no inhibitory effect here. * **Cytochrome P450:** Caffeine is actually a **substrate** for CYP1A2, not a primary inhibitor. In fact, other drugs (like ciprofloxacin) inhibit CYP1A2, leading to caffeine toxicity. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Caffeine citrate is the DOC for **Apnea of Prematurity** due to its wider therapeutic index and longer half-life compared to theophylline. * **Therapeutic Range:** Theophylline has a narrow therapeutic window (10–20 µg/ml); caffeine is safer. * **Adverse Effects:** High doses can cause tachycardia, restlessness, and increased gastric acid secretion.

Q: Which of the following is NOT a feature of opioid intake?

Dilated pupils. **Explanation:** The correct answer is **D. Dilated pupils**. Opioids are central nervous system (CNS) depressants that typically cause **miosis** (pinpoint pupils), not dilation. **1. Why "Dilated Pupils" is the correct choice:** Opioids stimulate the **Edinger-Westphal nucleus** of the oculomotor nerve (CN III), leading to parasympathetic overactivity and constriction of the pupil (miosis). This is a hallmark sign of opioid use and overdose. In contrast, dilated pupils (mydriasis) are usually seen during **opioid withdrawal** or in specific cases like Pethidine (Meperidine) toxicity, which has atropine-like anticholinergic effects. **2. Why the other options are incorrect:** * **A & B (Relaxation and Euphoria):** Opioids act on **mu (μ) receptors** in the reward pathway of the brain (ventral tegmental area and nucleus accumbens), leading to a sense of well-being, detachment from anxiety, and intense pleasure. * **C (Analgesia):** This is the primary therapeutic effect of opioids. They inhibit the transmission of pain signals in the spinal cord and alter the perception of pain in the higher cortical centers. **High-Yield Clinical Pearls for NEET-PG:** * **The Triad of Opioid Overdose:** Coma, Pinpoint pupils, and Respiratory depression. * **Tolerance:** Tolerance develops to most effects (analgesia, euphoria, respiratory depression) **EXCEPT** for miosis and constipation. These two signs remain even in chronic users. * **Exception to Miosis:** **Pethidine** causes mydriasis due to its antimuscarinic action. * **Antidote:** **Naloxone** is the drug of choice for acute opioid poisoning (short-acting IV antagonist).

Q: Which of the following is not an FDA-approved indication for the use of modafinil as an adjunct?

Major depression and associated lethargy. **Explanation:** Modafinil is a non-amphetamine wake-promoting agent (eugeroic) that acts primarily by inhibiting the reuptake of dopamine and modulating hypothalamic neuropeptides like **orexin/hypocretin**. **1. Why Option A is Correct:** While modafinil is frequently used **off-label** as an augmenting agent in treatment-resistant Major Depressive Disorder (MDD) to combat fatigue and "brain fog," it is **not FDA-approved** for this indication. Clinical trials have shown mixed results regarding its efficacy as a primary adjunct for depression compared to standard stimulants or antidepressants. **2. Analysis of Incorrect Options (FDA-Approved Indications):** * **Narcolepsy (Option B):** Modafinil is the first-line pharmacological treatment for excessive daytime sleepiness (EDS) associated with narcolepsy. * **Obstructive Sleep Apnea (Option C):** It is approved as an adjunct to CPAP therapy for patients who continue to experience significant daytime sleepiness despite effective airway pressure treatment. * **Shift Work Sleep Disorder (Option D):** It is approved for improving wakefulness in patients with excessive sleepiness due to non-traditional work schedules. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism:** Increases synaptic dopamine by blocking the Dopamine Transporter (DAT). It also increases histamine levels in the hypothalamus. * **Side Effects:** Headache (most common), nausea, and nervousness. Rarely, it can cause life-threatening rashes like **Stevens-Johnson Syndrome (SJS)**. * **Advantage over Amphetamines:** Lower abuse potential (Schedule IV drug), less peripheral sympathomimetic stimulation (less tachycardia/hypertension), and no rebound hypersomnolence. * **Armodafinil:** The R-enantiomer of modafinil with a longer half-life, also FDA-approved for the same three indications.

Q: Which anticonvulsant is considered safe in patients with hepatic porphyria?

Clonazepam. **Explanation:** The primary biochemical trigger for acute attacks in **Hepatic Porphyrias** (such as Acute Intermittent Porphyria) is the induction of the enzyme **ALA Synthase-1 (ALAS1)**. Most anticonvulsants induce the Cytochrome P450 (CYP450) system, which increases the demand for heme. This depletion of the regulatory heme pool removes the feedback inhibition on ALAS1, leading to the toxic accumulation of porphyrin precursors like ALA and PBG. * **Why Clonazepam is Correct:** Benzodiazepines, specifically **Clonazepam** and **Lorazepam**, are considered safe because they do not significantly induce the CYP450 system or ALAS1. They are the drugs of choice for managing seizures in porphyric patients. * **Why Incorrect Options are Wrong:** * **Phenytoin and Carbamazepine:** These are potent **enzyme inducers**. They significantly stimulate ALAS1 and are notorious for precipitating life-threatening porphyric crises. * **Paraldehyde:** While historically used, it is generally avoided as it is considered potentially porphyrinogenic in various clinical databases. **High-Yield Clinical Pearls for NEET-PG:** * **Safe Anticonvulsants:** Clonazepam, Gabapentin, Levetiracetam, and Magnesium Sulfate (for eclampsia). * **Unsafe Drugs (Porphyria Triggers):** Barbiturates (most common trigger), Sulfonamides, Estrogens, Griseofulvin, and Rifampin. * **Management Tip:** The definitive treatment for an acute porphyria attack is **Intravenous Hematin (Heme arginate)**, which provides exogenous heme to suppress ALAS1 through negative feedback. Glucose loading (high carbohydrate diet) also helps inhibit ALAS1.

Q: Natalizumab is used in the treatment of which condition?

Multiple sclerosis. **Explanation:** **Natalizumab** is a humanized monoclonal antibody that targets the **$\alpha$4-integrin** (VLA-4) subunit. Its primary mechanism involves blocking the interaction between $\alpha$4-integrin on the surface of leukocytes and **VCAM-1** (Vascular Cell Adhesion Molecule-1) on vascular endothelial cells. By inhibiting this adhesion, it prevents leukocytes from crossing the blood-brain barrier and entering the Central Nervous System (CNS), thereby reducing the inflammatory destruction of myelin in **Multiple Sclerosis (MS)**. It is also used in Crohn’s disease. **Analysis of Incorrect Options:** * **B. Breast Carcinoma:** Treatment typically involves Trastuzumab (anti-HER2) or Pertuzumab, not Natalizumab. * **C. Psoriasis:** Common biologics used include Infliximab (anti-TNF$\alpha$), Ustekinumab (anti-IL-12/23), or Secukinumab (anti-IL-17A). * **D. B-cell Lymphoma:** Rituximab (anti-CD20) is the classic monoclonal antibody used for this condition. **High-Yield Clinical Pearls for NEET-PG:** * **PML Risk:** The most significant adverse effect of Natalizumab is **Progressive Multifocal Leukoencephalopathy (PML)**, caused by the reactivation of the **JC virus**. Patients must be screened for JC virus antibodies before starting therapy. * **Mechanism Mnemonic:** Natalizumab "prevents **N**eutrophils/leukocytes from **A**dhering" to the endothelium. * **FDA Indication:** It is generally reserved as a second-line therapy for relapsing-remitting MS due to the risk of PML.

Q: Which of the following local anesthetics is NOT an amide?

Procaine. Local anesthetics are clinically classified into two main groups based on their chemical linkage: **Amides** and **Esters**. ### 1. Why Procaine is the Correct Answer **Procaine** is an **ester-linked** local anesthetic. Esters are characterized by having a single "i" in their name (e.g., Procaine, Chloroprocaine, Tetracaine, Benzocaine). They are metabolized by plasma pseudocholinesterase and are more likely to cause allergic reactions due to the formation of para-aminobenzoic acid (PABA). ### 2. Why the Other Options are Incorrect Options A, C, and D are all **amide-linked** local anesthetics. A simple mnemonic for NEET-PG is that all amides contain **two "i"s** in their name: * **Lignocaine (Lidocaine):** The most commonly used amide; has a rapid onset and intermediate duration. * **Mepivacaine:** An amide with a pharmacological profile similar to lidocaine but lacks its vasodilator properties. * **Dibucaine:** A potent, long-acting amide. It is clinically significant for the "Dibucaine Number" test used to detect atypical pseudocholinesterase. ### 3. High-Yield Clinical Pearls for NEET-PG * **Metabolism:** Amides are metabolized primarily in the **liver** (by CYP450 enzymes), whereas esters are metabolized in the **plasma** (by pseudocholinesterase). * **Allergy:** True allergic reactions are rare with amides but common with esters (due to PABA). * **Cocaine:** It is the only ester that is a potent vasoconstrictor (all others are vasodilators). * **Prilocaine:** An amide known for causing **methemoglobinemia** at high doses. * **Bupivacaine:** The most cardiotoxic local anesthetic; Intralipid (20% lipid emulsion) is the antidote for toxicity.

Q: What is the drug of choice for absence seizures in children younger than 3 years of age?

Ethosuximide. **Explanation:** **1. Why Ethosuximide is the Correct Answer:** Ethosuximide is the **Drug of Choice (DOC)** for absence seizures (petit mal) in children. The underlying pathophysiology of absence seizures involves abnormal T-type Calcium channels in thalamic neurons, which create rhythmic 3-Hz spike-and-wave discharges. Ethosuximide works specifically by **inhibiting these T-type $Ca^{2+}$ channels**, effectively suppressing the paroxysmal activity without the significant sedative or systemic side effects associated with broader-spectrum anticonvulsants. **2. Why the Other Options are Incorrect:** * **Carbamazepine (Option B):** This is a narrow-spectrum agent used for focal and tonic-clonic seizures. Crucially, Carbamazepine (along with Phenytoin) can **exacerbate or worsen** absence seizures and is strictly contraindicated. * **Lamotrigine (Option C):** While Lamotrigine is effective against absence seizures and is often used as a second-line agent or in mixed seizure disorders, it is not the primary DOC due to the risk of Stevens-Johnson Syndrome (SJS), especially during rapid dose titration. * **Phenytoin (Option D):** Similar to Carbamazepine, Phenytoin is a sodium channel blocker that is ineffective against absence seizures and may increase the frequency of attacks. **3. NEET-PG High-Yield Clinical Pearls:** * **DOC for Absence Seizures:** Ethosuximide (if only absence seizures are present); Valproate (if absence seizures are accompanied by Generalized Tonic-Clonic Seizures/GTCS). * **Classic EEG Finding:** 3-Hz spike-and-wave discharges. * **Side Effects of Ethosuximide:** Remember the mnemonic **EFGH** – **E**thosuximide causes **F**atigue, **G**I distress, **H**eadache (and rarely Hematologic issues/SJS). * **Valproate vs. Ethosuximide:** In children <2 years, Valproate carries a high risk of fatal hepatotoxicity, making Ethosuximide a safer profile choice for pure absence seizures.

Q: Magnesium sulfate is contraindicated in which of the following conditions?

Myasthenia gravis. **Explanation:** **1. Why Myasthenia Gravis is the Correct Answer:** Magnesium sulfate ($MgSO_4$) acts as a neuromuscular blocking agent by inhibiting the release of acetylcholine (ACh) from the presynaptic nerve terminals and decreasing the sensitivity of the motor endplate to ACh. In **Myasthenia Gravis**, there is already a functional deficiency of ACh receptors due to autoantibodies. Administering $MgSO_4$ can precipitate a **myasthenic crisis** or severe respiratory paralysis by further weakening neuromuscular transmission. Therefore, it is strictly contraindicated. **2. Analysis of Incorrect Options:** * **Placenta Previa:** $MgSO_4$ is not contraindicated here. In fact, if a patient with placenta previa requires preterm delivery (before 32 weeks), $MgSO_4$ may be used for fetal neuroprotection. * **Preeclampsia:** This is the **primary indication** for $MgSO_4$. It is the drug of choice for preventing seizures in preeclampsia and controlling seizures in eclampsia (Pritchard or Zuspan regimens). * **Epilepsy:** While $MgSO_4$ is not the standard treatment for chronic epilepsy, it is not contraindicated. However, it is important to distinguish between an eclamptic seizure and an epileptic seizure in a pregnant patient to ensure appropriate anticonvulsant therapy. **3. High-Yield Clinical Pearls for NEET-PG:** * **Absolute Contraindications of $MgSO_4$:** Myasthenia Gravis, Heart Block, and Myocardial Damage. * **Monitoring Parameters:** Always check for **Patellar reflex** (first to disappear), **Respiratory rate** (>12/min), and **Urine output** (>30 ml/hr or 100 ml/4hr) before each dose. * **Therapeutic Range:** 4–7 mEq/L. * **Antidote:** 10 ml of 10% **Calcium Gluconate** IV (administered slowly over 10 minutes). * **Renal Failure:** Since $MgSO_4$ is excreted solely by the kidneys, the dose must be omitted or reduced if urine output is low.

Q: Regarding adverse reactions of anticonvulsants, all are true EXCEPT:

Carbamazepine - Breech presentation. **Explanation:** This question tests knowledge of the teratogenic and systemic adverse effects of common antiepileptic drugs (AEDs). **1. Why Option B is the Correct Answer:** **Carbamazepine** is associated with **Neural Tube Defects (NTDs)**, craniofacial abnormalities, and fingernail hypoplasia. **Breech presentation** is a mechanical obstetric complication related to fetal positioning and is **not** a drug-induced malformation or a recognized adverse effect of Carbamazepine. Therefore, this statement is false. **2. Analysis of Incorrect Options (True Statements):** * **A. Phenobarbitone - Cardiovascular defect:** Phenobarbitone is a known teratogen. Maternal use is associated with congenital heart diseases (e.g., septal defects) and the "Fetal Hydantoin-like Syndrome." * **C. Phenytoin - Gum hyperplasia [1]:** This is a classic, high-yield side effect occurring in about 50% of patients. It is caused by the stimulation of platelet-derived growth factor (PDGF) and fibroblast proliferation. * **D. Sodium valproate - Neural tube defect:** Valproate has the highest teratogenic risk among AEDs. It interferes with folate metabolism, leading specifically to **spina bifida** (incidence ~1-2%). **3. High-Yield Clinical Pearls for NEET-PG:** * **Fetal Hydantoin Syndrome (Phenytoin):** Characterized by cleft lip/palate, microcephaly, and hypoplastic phalanges/nails. * **Valproate:** Most common cause of NTDs; supplementation with high-dose Folic Acid (5mg) is mandatory for women of childbearing age on AEDs. * **Drug of Choice (DOC) in Pregnancy:** **Lamotrigine** and **Levetiracetam** are currently considered the safest AEDs regarding major malformations. * **Enzyme Induction:** Phenytoin, Carbamazepine, and Phenobarbital are potent **CYP450 inducers**, which can lead to Vitamin K deficiency in the neonate (causing hemorrhagic disease of the newborn).

Q: Which one of the following is an indication for valproate?

All of the above. **Explanation:** Valproate (Sodium Valproate/Valproic Acid) is a broad-spectrum anti-epileptic drug with a multifaceted mechanism of action. It increases GABA levels (by inhibiting GABA transaminase), blocks voltage-gated sodium channels, and inhibits T-type calcium channels. This versatility makes it effective across various neurological and psychiatric conditions. * **Option A (Prophylaxis for migraine):** Valproate is a first-line agent for the prophylactic treatment of migraine. It reduces the frequency and severity of attacks, likely by modulating GABAergic neurotransmission and reducing neuronal hyperexcitability. * **Option B (Complex partial seizures):** As a broad-spectrum anticonvulsant, Valproate is effective against almost all seizure types, including generalized (Tonic-clonic, Absence, Myoclonic) and focal seizures (Simple and Complex partial). * **Option C (Acute mania):** Valproate acts as a potent mood stabilizer. It is FDA-approved for the treatment of acute manic or mixed episodes associated with Bipolar Disorder, often showing efficacy in patients who do not respond to Lithium. Since all three clinical scenarios are established indications, **Option D** is the correct answer. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Valproate is the DOC for **Myoclonic seizures** and is preferred for idiopathic generalized epilepsies. * **Teratogenicity:** It is highly teratogenic, causing **Neural Tube Defects** (e.g., Spina Bifida). Avoid in pregnancy; if essential, supplement with high-dose Folic Acid. * **Side Effects:** Remember the mnemonic **VALPROATE**: **V**omiting, **A**lopecia (curly hair), **L**iver toxicity (Hepatotoxicity), **P**ancreatitis, **R**etention of fat (Weight gain), **O**edema, **A**taxia, **T**hrombocytopenia, and **E**ncephalopathy (due to Hyperammonemia).

Question 1

Which enzyme is inhibited by caffeine?

Accepted Answer

Phosphodiesterase

Answer

Monoamine oxidase

Answer

Alcohol dehydrogenase

Answer

Cytochromo P 450

Question 2

Which of the following is NOT a feature of opioid intake?

Accepted Answer

Dilated pupils

Answer

Feeling of relaxation

Answer

Euphoria

Answer

Analgesia

Question 3

Which of the following is not an FDA-approved indication for the use of modafinil as an adjunct?

Accepted Answer

Major depression and associated lethargy

Answer

Narcolepsy

Answer

Obstructive sleep apnea

Answer

Shift work sleep disorder

Question 4

Which anticonvulsant is considered safe in patients with hepatic porphyria?

Accepted Answer

Clonazepam

Answer

Paraldehyde

Answer

Phenytoin

Answer

Carbamazepine

Question 5

Natalizumab is used in the treatment of which condition?

Accepted Answer

Multiple sclerosis

Answer

Breast carcinoma

Answer

Psoriasis

Answer

B cell lymphoma

Question 6

Which of the following local anesthetics is NOT an amide?

Accepted Answer

Procaine

Answer

Lignocaine

Answer

Mepivacaine

Answer

Dibucaine

Question 7

What is the drug of choice for absence seizures in children younger than 3 years of age?

Accepted Answer

Ethosuximide

Answer

Carbamazepine

Answer

Lamotrigine

Answer

Phenytoin

Question 8

Magnesium sulfate is contraindicated in which of the following conditions?

Accepted Answer

Myasthenia gravis

Answer

Placenta previa

Answer

Preeclampsia

Answer

Epilepsy

Question 9

Regarding adverse reactions of anticonvulsants, all are true EXCEPT:

Accepted Answer

Carbamazepine - Breech presentation

Answer

Phenobarbitone - Cardiovascular defect

Answer

Phenytoin - Gum hyperplasia

Answer

Sodium valproate - Neural tube defect

Question 10

Which one of the following is an indication for valproate?

Accepted Answer

All of the above

Answer

Prophylaxis for migraine

Answer

Complex partial seizures

Answer

Acute mania

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?